Keyphrases
Metabolic Biomarkers
100%
Cardiovascular Complications
100%
Infection Severity
76%
COVID-19
66%
Inflammatory Biomarkers
66%
SARS-CoV-2 Infection
50%
End Organ
33%
Molecular Mechanism
33%
Organ Complications
33%
Novel COVID-19
23%
Diagnostic Progression
23%
Intense Monitoring
23%
Sensory Analysis
23%
Patients with COVID-19
23%
Complex Heterogeneity
23%
Predictors of Infection
23%
Clinical High Risk
16%
Progression Biomarkers
16%
Clinically Significant
16%
Inflammation
16%
Risk Factors
16%
Biological Specimens
16%
Novel Therapeutics
16%
Diverse Populations
16%
Therapeutic Intervention
16%
Metabolism
16%
Coronavirus
16%
CoV-2
16%
Racial Differences
16%
Disease Progression
16%
North Carolina
16%
Integrated EHR
6%
Omics Data
6%
Intensive Monitoring
6%
Infection Biomarkers
6%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Cardiovascular Disease
100%
Infection
100%
SARS Coronavirus
100%
Severe Acute Respiratory Syndrome
36%
Coronavirinae
15%
Inflammation
15%
Disease Exacerbation
15%
Tamsulosin
15%
Medicine and Dentistry
Cardiovascular Disease
66%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Infection
66%
Biological Marker
66%
COVID-19
22%
Severe Acute Respiratory Syndrome
22%
Disease Exacerbation
15%
Tamsulosin
11%
Cardiovascular System
11%
Diagnosis
11%
Race Difference
11%
Specimen
11%
Coronavirinae
11%